Home > Healthcare > Medical Devices > Therapeutic Devices > Interventional Cardiology & Peripheral Vascular Devices Market

Interventional Cardiology & Peripheral Vascular Devices Market Size

Report ID: GMI1964
Published Date: Mar 2023
Report Format: PDF

Download Free Sample

Interventional Cardiology & Peripheral Vascular Devices Market Size

Interventional Cardiology & Peripheral Vascular Devices Market size exceeded USD 22 billion in 2022. The industry is expected to register more than 7.5% CAGR through 2023-2032, considering low physical activity engagement and rising chronic disease incidence

To get key market trends

Download Free Sample

Lifestyle changes and the adoption of unhealthy habits including alcohol consumption are contributing to the growing prevalence of cardiovascular diseases such as heart attacks. Coronary catheterization and peripheral vascular interventional procedures will emerge as a preferred intervention to lower the disease burden. Obesity is also recognized as one of the public health problems worldwide.

Interventional Cardiology & Peripheral Vascular Devices Market Report Attributes
Report Attribute	Details
Base Year:	2022
Interventional Cardiology & Peripheral Vascular Devices Market Size in 2022:	USD 22 Billion
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	7.5%
2032 Value Projection:	USD 47 Billion
Historical Data for:	2018 to 2022
No. of Pages:	183
Tables, Charts & Figures:	371
Segments covered:	Product, Application, End-use, and Region
Growth Drivers:	Growing prevalence of vascular diseases worldwide Technological advancements in peripheral vascular devices Rising adoption of minimally invasive procedures Increasing government spending pertaining to cardiovascular diseases burden
Pitfalls & Challenges:	Stringent regulatory framework Post-procedural complications associated with devices

Learn more about the key segments shaping this market

Download Free Sample

Obesity is considered a risk factor for peripheral arterial disease development. The increase in the obese population will therefore accelerate hospital admissions and create lucrative growth opportunities for manufacturers of cardiology equipment and peripheral vascular medical devices. However, these devices require high capital investment, and their regulatory approvals are time-consuming. They possess high-risk levels and are subject to strict regulations, thereby restricting market expansion.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for interventional cardiology & peripheral vascular devices exceeded USD 22 billion in 2022 and will register over 7.5% CAGR through 2023-2032, considering low physical activity engagement and growing chronic disease incidence.

Ambulatory surgical centers segment is poised to depict over 8% CAGR through 2023-2032, driven by the shifting preference toward minimally invasive procedures.

North American interventional cardiology & peripheral vascular devices market is slated to surpass USD 13 billion by 2032, owing to the presence of state-of-the-art healthcare facilities for minimally invasive procedures for cardiac conditions.

Major manufacturers of interventional cardiology & peripheral vascular systems include B. Braun Melsungen AG, C.R. Bard (Becton Dickinson and Company), Cardinal Health, Medtronic plc, Boston Scientific Corporation, and Abbott Laboratories, among others.